Accessibility Statement Skip Navigation
  • Back to Global Sites
  • +972-77-2005042
  • Blog
  • Journalists
  • GDPR
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +972-77-2005042 from 8 AM - 11 PM IL

    • Contact
    • Contact

      +972-77-2005042
      from 8 AM - 11 PM IL

Close menu
  • News
  • Products
  • Contact
    • Request More Information
    • Journalists
    • GDPR

    Eva Longoria Announced as InMode Global Brand Ambassador

    InMode Logo (PRNewsfoto/InMode)

    News provided by

    InMode LTD.

    29 Sep, 2022, 15:00 IDT

    Share this article

    Share this article


    Partnership to Empower Women and Drive Awareness of InMode's Leading Procedures

    IRVINE, Calif., Sept. 29, 2022 /PRNewswire/ -- InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, proudly unveils their Global Brand Ambassador, award-winning actress, director, and producer Eva Longoria.

    Continue Reading
    Eva Longoria, InMode Global Brand Ambassador
    Eva Longoria, InMode Global Brand Ambassador

    Over the last 20 years, Eva Longoria has made her mark as an actress, producer, philanthropist, entrepreneur and mom. Celebrated for her beloved role on Desperate Housewives and critically acclaimed for her directorial roles in her documentary La Guerra Civil and the upcoming highly anticipated feature film Flamin' Hot, Longoria continues to be one of the most significant trailblazers in entertainment for women and the Latinx community.

    The campaign with InMode aims to highlight Longoria's journey and how the company's suite of treatments provides solutions to make her feel her personal best. After giving birth to her son, Longoria began using InMode technologies to help achieve natural, sculpted results. She continues to use InMode's Morpheus8 Body and EvolveX Transform for skin remodeling, toning, and maintenance.

    "I am looking forward to telling my story around my post-delivery body as InMode's Global Ambassador," says Longoria. "I live an active lifestyle and take the absolute best care of my body, however following the birth of my son, I noticed physical changes that I couldn't address through my regular routine and diet. I turned to InMode's EvolveX Transform and Morpheus8 Body treatments to address those concerns, and I love the results."

    EvolveX Transform is a hands-free, non-invasive total body treatment used to transform skin, treat fat, and tone muscles. Morpheus8 Body is a safe and effective, minimally invasive technology for subdermal remodeling, targeting the deeper layers of the skin to boost collagen.

    "InMode is thrilled to partner with Eva Longoria. Eva's personal and genuine experience with InMode technologies makes her the perfect person to share her story worldwide," said Shakil Lakhani, President of InMode North America.

    About InMode

    InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radiofrequency ("RF") technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology. For more information about InMode and its wide array of medical technologies, visit www.inmodemd.com.

    SOURCE InMode LTD.

    Modal title

    Also from this source

    InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook

    InMode Reports Third Quarter 2026 Financial Results: Quarterly GAAP Revenues of $92.1 Million; Reaffirms Full-Year 2026 Financial Outlook

    InMode Ltd. (Nasdaq: INMD) ("InMode"), a leading global provider of innovative medical technologies, today announced its consolidated financial...

    InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

    InMode to Report Third Quarter 2026 Financial Results on November 11, 2026, Expects Third Quarter Revenue of $91.8 Million to $92.0 Million, Reiterates FY 2026 Revenue Guidance Between $365M-$375M

    InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial...

    More Releases From This Source

    Contact PR Newswire

    • +972-77-2005042
      from 8 AM - 11 PM IL

    Global Sites

    • APAC
    • APAC - Traditional Chinese
    • Asia
    • Brazil
    • Canada
    • Czech
    • Denmark
    • Finland
    • France
    • Germany

     

    • India
    • Indonesia
    • Israel
    • Italy
    • Mexico
    • Middle East
    • Middle East - Arabic
    • Netherlands
    • Norway
    • Poland

     

    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States

    Do not sell or share my personal information:

    • Submit via [email protected] 
    • Call Privacy toll-free: 877-297-8921
    Global Sites
    • Asia
    • Brazil
    • Canada
    • Csezh
    • Denmark
    • Finland
    • France
    • Germany
    • India
    • Israel
    • Italie
    • Mexico
    • Middle East
    • Netherlands
    • Norway
    • Poland
    • Portugal
    • Russia
    • Slovakia
    • Spain
    • Sweden
    • United Kingdom
    • United States
    +972-77-2005042
    from 8 AM - 11 PM IL
    • Terms of Use
    • Privacy Policy
    • Information Security Policy
    • Site Map
    • Cookie Settings
    Copyright © 2026 Cision US Inc.